Results
- Showing results for:
- Reset all filters
Search results
-
Journal articleFreeman R, Moore LSP, Charlett A, et al., 2015,
Exploring the epidemiology of carbapenem-resistant Gram-negative bacteria in west London and the utility of routinely collected hospital microbiology data
, JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, Vol: 70, Pages: 1212-1218, ISSN: 0305-7453- Author Web Link
- Cite
- Citations: 19
-
Journal articleJones P, Moore LSP, Donaldson H, 2015,
Evolution of antibiotic resistance in bacteria involved in urinary tract infections: A 3-year London experience
, AMERICAN JOURNAL OF INFECTION CONTROL, Vol: 43, Pages: 419-420, ISSN: 0196-6553 -
Journal articleCastro-Sanchez E, Holmes AH, 2015,
Impact of organizations on healthcare-associated infections
, JOURNAL OF HOSPITAL INFECTION, Vol: 89, Pages: 346-350, ISSN: 0195-6701- Author Web Link
- Cite
- Citations: 21
-
Journal articleDrumright LN, Frost SD, Elliot AJ, et al., 2015,
Assessing the use of hospital staff influenza-like absence (ILA) for enhancing hospital preparedness and national surveillance
, BMC INFECTIOUS DISEASES, Vol: 15, ISSN: 1471-2334- Author Web Link
- Cite
- Citations: 6
-
Journal articleHolmes A, Castro-Sánchez E, Ahmad R, 2015,
Guidelines in infection prevention: Current challenges and limitations
, British Journal of Health Care Management, Vol: 21, Pages: 275-277, ISSN: 1358-0574- Cite
- Citations: 5
-
Journal articleMoore LSP, Freeman R, Gilchrist MJ, et al., 2014,
Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108717 clinical isolates from primary, secondary and tertiary care patients in London.
, Journal of Antimicrobial Chemotherapy, Vol: 69, Pages: 3409-3422, ISSN: 1460-2091Objectives We examined the 4 year trend in antimicrobial susceptibilities and prescribing across levels of care at two London teaching hospitals and their multisite renal unit, and for the surrounding community.Methods Laboratory and pharmacy information management systems were interrogated, with antimicrobial use and susceptibilities analysed between hospitals, within hospitals and over time.Results A total of 108 717 isolates from 71 687 patients were identified, with significant differences (at P < 0.05) in antimicrobial susceptibility between and within hospitals. Across the 4 years, rates of ESBL-/AmpC-producing Enterobacteriaceae ranged from 6.4% to 10.7% among community isolates, 17.8% to 26.9% at ward level and 25.2% to 52.5% in critical care. Significant variations were also demonstrated in glycopeptide-resistant enterococci (ward level 6.2%–17.4%; critical care 21.9%–56.3%), MRSA (ward level 18.5%–38.2%; critical care 12.5%–47.9%) and carbapenem-resistant Pseudomonas spp. (ward level 8.3%–16.9%; critical care 19.9%–53.7%). Few instances of persistently higher resistance were seen between the hospitals in equivalent cohorts, despite persistently higher antimicrobial use in Hospital 1 than Hospital 2. We found significant fluctuations in non-susceptibility year on year across the cohorts, but with few persistent trends.Conclusions The marked heterogeneity of antimicrobial susceptibilities between hospitals, within hospitals and over time demands detailed, standardized surveillance and appropriate benchmarking to identify possible drivers and effective interventions. Homogeneous antimicrobial policies are unlikely to continue to be suitable as individual hospitals join hospital networks, and policies should be tailored to local resistance rates, at least at the hospital level, and possibly with finer resolution, particularly for critical care.
-
Journal articleKing D, Jabbar A, Charani E, et al., 2014,
Redesigning the 'choice architecture' of hospital prescription charts: a mixed methods study incorporating in situ simulation testing
, BMJ OPEN, Vol: 4, ISSN: 2044-6055- Author Web Link
- Open Access Link
- Cite
- Citations: 9
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.